↓ Skip to main content

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
8 Mendeley